AIG
VRDN icon

American International Group’s Viridian Therapeutics VRDN Stock Holding History

American International Group’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,515
Closed -$429K – 2656
2024
Q1 		$429K Buy
24,515
+3,266
+15% +$63.3K ﹤0.01% 1738
2023
Q4 		$463K Buy
21,249
+189
+0.9% +$2.98K ﹤0.01% 1705
2023
Q3 		$323K Buy
21,060
+748
+4% +$14.3K ﹤0.01% 1850
2023
Q2 		$483K Buy
20,312
+1,861
+10% +$47.7K ﹤0.01% 1659
2023
Q1 		$469K Buy
18,451
+561
+3% +$18K ﹤0.01% 1637
2022
Q4 		$523K Buy
17,890
+5,296
+42% +$122K ﹤0.01% 1562
2022
Q3 		$258K Buy
12,594
+516
+4% +$9.28K ﹤0.01% 2012
2022
Q2 		$140K Buy
+12,078
New +$162K ﹤0.01% 2400
2019
Q2 		– Sell
-1,105
Closed -$46K – 3154
2019
Q1 		$46K Sell
1,105
-36
-3% -$1.63K ﹤0.01% 2901
2018
Q4 		$52K Sell
1,141
-9
-0.8% -$520 ﹤0.01% 2877
2018
Q3 		$96K Buy
1,150
+36
+3% +$3.4K ﹤0.01% 2864
2018
Q2 		$107K Buy
1,114
+388
+53% +$41K ﹤0.01% 2750
2018
Q1 		$76K Buy
726
+135
+23% +$14.7K ﹤0.01% 2782
2017
Q4 		$93K Buy
591
+26
+5% +$3.31K ﹤0.01% 2760
2017
Q3 		$77K Buy
565
+43
+8% +$7.23K ﹤0.01% 2740
2017
Q2 		$101K Buy
+522
New +$88.1K ﹤0.01% 2721
2015
Q3 		– Sell
-1
Closed -$548 – 5071
2015
Q2 		$548 Buy
+1
New +$405 ﹤0.01% 5020

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

American International Group's VRDN Position: Q2 2024 in Review

American International Group sold out of Viridian Therapeutics (VRDN) in Q2 2024, closing a stake of 24,515 shares — an estimated $429K sold.

American International Group first reported a position in VRDN in Q2 2015 and held it in 17 quarters. The position peaked at $523K in Q4 2022. 138 funds tracked by Wall St. Rank hold VRDN as of Q2 2024.

  • American International Group reported no remaining Viridian Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 24,515 Viridian Therapeutics shares in Q2 2024, an estimated $429K.
  • American International Group first reported a position in Viridian Therapeutics in Q2 2015 and held it in 17 quarters.
  • American International Group's Viridian Therapeutics position peaked at $523K in Q4 2022.
  • 138 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.